Preferred Name |
Deferiprone |
|
Synonyms |
Deferiprone 4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl- DEFERIPRONE DN-180-01-AF APO-066 CP20 Ferriprox |
|
Definitions |
An orally bioavailable bidentate ligand with iron chelating activity. Deferiprone binds to iron in a 3:1 (ligand:iron) molar ratio. By binding to iron, deferiprone is able to remove excess iron from the body. |
|
ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C73030 |
|
Accepted_Therapeutic_Use_For |
Hemosiderosis |
|
CAS_Registry |
30652-11-0 |
|
Chemical_Formula |
C7H9NO2 |
|
code |
C73030 |
|
Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 |
|
Contributing_Source |
FDA HemOnc |
|
DEFINITION |
An orally bioavailable bidentate ligand with iron chelating activity. Deferiprone binds to iron in a 3:1 (ligand:iron) molar ratio. By binding to iron, deferiprone is able to remove excess iron from the body. |
|
FDA_UNII_Code |
2BTY8KH53L |
|
FULL_SYN |
Deferiprone 4(1H)-Pyridinone, 3-hydroxy-1,2-dimethyl- DEFERIPRONE DN-180-01-AF APO-066 CP20 Ferriprox |
|
label |
Deferiprone |
|
Legacy Concept Name |
Deferiprone |
|
NCI_Drug_Dictionary_ID |
761978 |
|
PDQ_Closed_Trial_Search_ID |
761978 |
|
PDQ_Open_Trial_Search_ID |
761978 |
|
Preferred_Name |
Deferiprone |
|
prefixIRI |
Thesaurus:C73030 |
|
Semantic_Type |
Pharmacologic Substance |
|
UMLS_CUI |
C0043832 |
|
subClassOf |